Evidence map›Paper›PMID 14728725›Full record

ArticleBMC cell biology2004

Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling.

Nieves Ibarrola, Irina Kratchmarova, Daisuke Nakajima, William P Schiemann, Aristidis Moustakas, Akhilesh Pandey, Matthias Mann

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. TGF-β signaling pathway mediated by deubiquitinating enzymes.Cellular and molecular life sciences : CMLS · 2019
    Review
  5. Article
  6. Review
  7. Article
  8. Regulation of TGF-β Family Signaling by Inhibitory Smads.Cold Spring Harbor perspectives in biology · 2017
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Noncanonical TGF-β signaling during mammary tumorigenesis.Journal of mammary gland biology and neoplasia · 2011
    Review
  18. NetSlim: high-confidence curated signaling maps.Database : the journal of biological databases and curation · 2011
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Nieves IbarrolaMcKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD 21205, USA. nibarro1@jhmi.edu
Irina Kratchmarova
Daisuke Nakajima
William P Schiemann
Aristidis Moustakas
Akhilesh Pandey
Matthias Mann
Johns Hopkins University · USUniversity of Southern Denmark · DKKazusa DNA Research Institute · JPLudwig Cancer Research · SEUniversity of Colorado Denver · US

Funding

VACCINES--A NEW PARADIGM FOR BREAST CANCERP50CA088843 · NCI · JOHNS HOPKINS UNIVERSITY · PI DAVIDSON, NANCY ELLEN · 2000 to 2010
$27.8M
NCI NIH HHS CA 88843NCI NIH HHS P50 CA088843
6 · The paper itself

Abstract

backgroundTransforming growth factor-betas (TGF-betas), bone morphogenetic proteins (BMPs) and activins are important regulators of developmental cell growth and differentiation. Signaling by these factors is mediated chiefly by the Smad family of latent transcription factors.

resultsThere are a large number of uncharacterized cDNA clones that code for novel proteins with homology to known signaling molecules. We have identified a novel molecule from the HUGE database that is related to a previously known molecule, AMSH (associated molecule with the SH3 domain of STAM), an adapter shown to be involved in BMP signaling. Both of these molecules contain a coiled-coil domain located within the amino-terminus region and a JAB (Domain in Jun kinase activation domain binding protein and proteasomal subunits) domain at the carboxy-terminus. We show that this novel molecule, which we have designated AMSH-2, is widely expressed and its overexpression potentiates activation of TGF-beta-dependent promoters. Coimmunoprecipitation studies indicated that Smad7 and Smad2, but not Smad3 or 4, interact with AMSH-2. We show that overexpression of AMSH-2 decreases the inhibitory effect of Smad7 on TGF-beta signaling. Finally, we demonstrate that knocking down AMSH-2 expression by RNA interference decreases the activation of 3TP-lux reporter in response to TGF-beta.

conclusionsThis report implicates AMSH and AMSH-2 as a novel family of molecules that positively regulate the TGF-beta signaling pathway. Our results suggest that this effect could be partially explained by AMSH-2 mediated decrease of the action of Smad7 on TGF-beta signaling pathway.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid SequenceCarrier ProteinsCell LineCell Line, TumorCloning, MolecularDNA-Binding ProteinsExonsFemaleGene ExpressionGenesHeLa CellsHL-60 CellsHumansIntronsK562 CellsAdaptor Proteins, Signal TransducingCarrier ProteinsDNA-Binding ProteinsLuciferasesPeptide HydrolasesRecombinant Fusion ProteinsRNA, Small InterferingSmad2 ProteinSMAD2 protein, humanSmad7 ProteinSMAD7 protein, humanSTAMBPL1 protein, humanTrans-ActivatorsTransforming Growth Factor betaUbiquitin Thiolesterase

Identifiers

PMID14728725
PMCPMC385422
OpenAlexW2136264857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.